Samsung's Ontruzant Becomes First Trastuzumab Biosimilar Approved In EU

 
• By Jung Won Shin
  
Samsung Bioepis
Samsung Bioepis researchers conducting a study • Source: Samsung Bioepis
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip